FDA & Healthcare Regulatory Considerations for Startups

For health tech and life science startups, two questions come early: does the FDA regulate the product, and which federal healthcare rules apply to the business model?

Join the Center for Technology Licensing (CTL) for FDA & Healthcare Regulatory Considerations for Startups, the next session in the Lab to Impact series. This virtual session is for Cornell and Weill Cornell Medicine researchers, clinicians, faculty innovators and aspiring founders developing medical devices, software, AI-enabled products, therapeutics or digital health businesses.

Attendees will get an overview of:

• How FDA regulates medical devices
• Where software as a medical device (SaMD) and AI-enabled products fit
• How FDA regulates pharmaceuticals
• Key federal healthcare regulatory considerations that apply to certain health tech and digital health business models

Speakers will be announced soon.

RSVP here.